publication . Article . Other literature type . 2013

The role of community pharmacists in screening and subsequent management of chronic respiratory diseases: a systematic review

Fathima M; Naik-Panvelkar P; Saini B; Carol Armour;
Open Access English
  • Published: 01 Dec 2013
  • Publisher: Centro de Investigaciones y Publicaciones Farmacéuticas
Abstract
Objective: The purpose of this review was to evaluate the role of community pharmacists in provision of screening with/without subsequent management of undiagnosed chronic obstructive pulmonary disease (COPD) and uncontrolled asthma. Methods: An extensive literature search using four databases (ie. Medline, PubMed, International Pharmaceutical Abstracts (IPA) and Scopus) with search terms pharmacy, screening, asthma or COPD was conducted. Searches were limited to the years 2003-2013, those in English and those reporting research with humans. Data retrieval, analysis and result presentation employed a scoping review method. Results: Seventeen articles met the inc...
Subjects
free text keywords: Mass Screening, Lung Diseases, Obstructive, Outcome Assessment (Health Care), Community Pharmacy Services, Professional Practice, Professional Role, Rastreo Masivo, Enfermedades Pulmonares Obstructivas, Evaluación de Procesos y Resultados (Atención de Salud), Servicios de Farmacia comunitaria, Práctica Profesional, Rol Profesional, Pharmaceutical Science, Asthma, medicine.disease, medicine, Pharmacist, Pharmacy, business.industry, business, Family medicine, medicine.medical_specialty, Psychological intervention, Risk assessment, Nursing, COPD, MEDLINE, Original Research, mesh:Mass Screening, mesh:Lung Diseases, Obstructive, mesh:Outcome Assessment (Health Care), mesh:Community Pharmacy Services, mesh:Professional Practice, mesh:Professional Role
Related Organizations
75 references, page 1 of 5

1. Thomas R, Parikh R, Paul P, Muliyil J. Population-based screening versus case detection. Indian J Ophthalmol. 2002;50(3):233-237.

2. National Health Priority Action Council (NHPAC). National Chronic Disease Strategy, Australian department of health and ageing, 2006. Online ISBN: 0642828695. http://www.health.gov.au/chronicdiseasestrategy (Accessed June 14 2013).

3. World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. 2007. http://www.who.int/gard/publications/chronic_respiratory_diseases.pdf (Accessed July 09 2013).

4. Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, FitzGerald JM. Economic burden of asthma: a systematic review. BMC Pulm Med. 2009;9:24. doi: 10.1186/1471-2466-9-24 [OpenAIRE]

5. GINA (Global Initiative for Asthma). Global strategy for asthma management and prevention 2009 (update). Bethesda, Maryland: National Institutes of Health, National Heart, Lung and Blood Institute. http://www.ginasthma.org/uploads/users/files/GINA_Report_2011.pdf. (Accessed July 09 2013).

6. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH. Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest. 2000;117(2):542-550.

7. Basheti IA, Armour CL, Bosnic-Anticevich SZ, Reddel HK. Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. J Allergy Clin Immunol. 2007;119(6):1537-1538. [OpenAIRE]

8. Holgate ST, Price D, Valovirta E. Asthma out of control? A structured review of recent patient surveys. BMC Pulm Med. 2006;6(Suppl 1):S2. [OpenAIRE]

9. Vieira JW, Silva AA, Oliveira FM. Knowledge and impact on disease management by asthmatic patients. Rev Bras Enferm. 2008;61(6):853-857.

10. Laforest L, Van Ganse E, Devouassoux G, Osman LM, Bauguil G, Chamba G. Patient-reported adverse events under asthma therapy: a community pharmacy-based survey. Clin Pharmacol Ther. 2007;82(2):167-172.

11. The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013. http://www.goldcopd.org/ (Accessed: July 09 2013).

12. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E; BOLD Collaborative Research Group. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741-750.

13. Lyngs AM, Backer V, Gottlieb V, Nybo B, Ostergaard MS, Frølich A. Early detection of COPD in primary care--the Copenhagen COPD Screening Project. BMC Public Health. 2010;10:524. doi: 10.1186/1471-2458-10-524

14. Hersberger KE, Renggli VP, Nirkko AC, Mathis J, Schwegler K, Bloch KE. Screening for sleep disorders in community pharmacies - evaluation of a campaign in Switzerland. J Clin Pharm Ther. 2006;31(1):35-41. [OpenAIRE]

15. Snella KA, Canales AE, Irons BK, Sleeper-Irons RB, Villarreal MC, Levi-Derrick VE, Greene RS, Jolly JL, Nelson AA. Pharmacy- and Community-Based Screenings for Diabetes and Cardiovascular Conditions in High-Risk Individuals. J Am Pharm Assoc (2003). 2006;46(3):370-377. [OpenAIRE]

75 references, page 1 of 5
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . Other literature type . 2013

The role of community pharmacists in screening and subsequent management of chronic respiratory diseases: a systematic review

Fathima M; Naik-Panvelkar P; Saini B; Carol Armour;